Sanofi - ADR (SNY): $53.42

-0.50 (-0.93%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Sanofi (SNY) Price Targets From Analysts

Use the tables below to see what analysts covering Sanofi think about its future price and what recommendations they have for investors and traders.

Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
20 $69.86 $50.47 $60.82 $53.8 13.05%

The Trend in the Analyst Price Target


Over the past 85 days, SNY's average price target has gone down $0.82.

Over the past 164 days, SNY's average upside potential has been 19.09%.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2020-11-20 20 69.86 50.47 60.82 50.52 20.39%
2020-11-19 20 69.86 50.47 60.82 50.88 19.54%
2020-11-10 20 68.20 50.47 60.71 50.17 21.01%
2020-10-31 20 68.20 49.54 60.54 45.30 33.64%
2020-09-30 20 68.99 50.27 61.46 50.17 22.5%
2020-09-22 19 68.99 50.27 62.06 49.86 24.47%
2020-09-16 19 68.99 50.27 62.14 51.81 19.94%
2020-09-05 19 68.09 50.27 61.71 49.47 24.74%
2020-08-27 19 68.09 50.27 61.64 50.76 21.43%
2020-08-20 19 68.09 50.27 61.66 51.40 19.96%
2020-08-12 19 65.51 50.26 61.01 51.79 17.8%
2020-08-07 19 65.35 50.26 61.00 51.51 18.42%
2020-07-23 19 64.51 48.32 59.53 52.13 14.2%
2020-07-16 19 64.51 48.32 59.21 52.96 11.8%
2020-07-08 19 64.02 47.73 58.80 51.52 14.13%
2020-07-01 19 64.02 47.73 58.83 51.27 14.75%
2020-06-25 19 64.12 48.17 58.29 51.86 12.4%
2020-06-18 20 63.54 47.68 57.85 51.43 12.48%
2020-06-11 20 63.00 48.25 57.81 NA NA%
2020-06-09 20 62.22 47.33 57.42 NA NA%

SNY Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs

The Trend in the Broker Recommendations


SNY's average broker recommendation rating worsened by 0.08 over the prior 61 days.

Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.

  • Sanofi's number of analysts covering the stock is higher than 93.67% of all US stocks.
  • SNY has a greater upside potential (average analyst target price relative to current price) than 14.82% of Pharmaceutical Products stocks.
  • SNY has a greater average analyst price target than 83.31% of Pharmaceutical Products stocks.
  • SNY has a lower variance in analysts' estimates than 62.59% of Pharmaceutical Products stocks.

Make investment decisions regarding SNY using the data that counts. Try POWR Ratings for free.


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.8169 seconds.